ISG15 and plasma cell myeloma: Lastly, the expression of ISG15 affects DMFS in breast cancer, PFS in ovarian cancer, DFS in pancreatic cancer, PPS in breast cancer, gastric cancer, AML, and myeloma, as well as EFS in AML and myeloma (Fig. 3C).